[Clinical trials of a new antiallergic substance, 9-(N-methyl-4-piperidylidene)-thioxasthene (BP 400)].
D018926:Anti-Allergic Agents; D001249:Asthma; D006634:Histamine H1 Antagonists; D006801:Humans; D006967:Hypersensitivity; D010880:Piperidines; D013892:Thioxanthenes
D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists; D010880:Piperidines; D013892:Thioxanthenes; C004327:pimethixene
ALLERGY; ANTIHISTAMINICS; ASTHMA